Skip to main content
SpringerLink
Log in

Adénomes non fonctionnels et thyréotropes au cours de la grossesse

  • Chapter
Pathologie hypophysaire et grossesse

  • 300 Accesses

Abtrait

Contrairement aux prolactinomes et, dans une moindre mesure, aux adénomes responsables ďune acromégalie ou ďune maladie de Cushing, les travaux concernant les adénomes non fonctionnels ou thyréotropes au cours de la grossesse sont peu nombreux. Néanmoins, du fait ďune meilleure approche diagnostique, la prévalence de ces deux pathologies s’accroît, et le problème de leur prise en charge au cours de la grossesse doit être posé. Une bonne connaissance des effets de la grossesse et de la lactation sur ľhypophyse s’impose, ainsi que la prise en compte du retentissement de la grossesse sur les adénomes, et des risques potentiels de ces tumeurs et de leur traitement au cours de la gestation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Comtois R, Beauregard H, Somma M et al. (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68: 860–6

    Article  PubMed  CAS  Google Scholar 

  2. Brada M, Rajan B, Traish D et al. (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38: 571–8

    CAS  Google Scholar 

  3. Jaffrain-Rea ML, Derome P, Bataini JP et al. (1993) Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970–1988). Eur J Med 2: 398–403

    PubMed  CAS  Google Scholar 

  4. Greenman Y, Tordjman K, Kisch E et al. (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocr Metab 80: 1577–83

    Article  PubMed  CAS  Google Scholar 

  5. Chanson P, Petrossians P (1998) Les adénomes hypophysaires non fonctionnels. John Libbey Eurotext, Paris

    Google Scholar 

  6. Turner HE, Stratton IM, Byrne JV et al. (1999) Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation — a follow-up study. Clin Endocrinol 51: 281–4

    Article  CAS  Google Scholar 

  7. Ebersold MJ, Quast LM, Laws ER Jr et al. (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64: 713–9

    PubMed  CAS  Google Scholar 

  8. Assayag M (1993) Les adénomes gonadotropes fonctionnels et non fonctionnels. Caractéristiques cliniques, hormonales, immunocytochimiques et évolutives de 81 cas. [Thèse Médecine] Paris

    Google Scholar 

  9. Greenman Y, Tordjman K, Kisch E et al. (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocr Metab 80: 1577–83

    Article  PubMed  CAS  Google Scholar 

  10. Kurosaki M, Ludecke DK, Flitsch J, Saeger W (2000) Surgical treatment of clinically nonsecreting pituitary adenomas in elderly patients. Neurosurgery 47: 843–8; discussion 848–9

    Article  PubMed  CAS  Google Scholar 

  11. Donadille F (2002) Adénomes hypophysaires non fonctionnels: étude rétrospective de 95 patients. [Thèse Médecine] Toulouse

    Google Scholar 

  12. Liuzzi A, Dallabonzana D, Oppizzi G et al. (1991) Is there a real medical treatment for « non-secreting » pituitary adenoma? In: Faglia G, Beck-Peccoz P, Ambrosi P et al. eds. Pituitary adnomas: new trends in basic and clinical research. Excerpta Medica, Amsterdam, p. 383–90

    Google Scholar 

  13. Warnet A (1996) Octréotide et tumeurs hypophysaires. In: Epelbaum J, ed. La somatostatine et ses analogues: de la recherche fondamentale à la clinique. John Libbey-Eurotext, Paris, p. 41–57

    Google Scholar 

  14. Enfer-Vattaut S (2005) Adénomes hypophysaires non fonctionnels et grossesse. [Thèse Médecine] Toulouse

    Google Scholar 

  15. Murata Y, Ando Y, Nagasaka T et al. (2003) Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocr Metab 88: 1988–93

    Article  PubMed  CAS  Google Scholar 

  16. Kupersmith MJ, Rosenberg C, Kleinberg D (1994) Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121(7): 473–7

    PubMed  CAS  Google Scholar 

  17. Sugita T, Seki K, Nagai Y et al. (2005) Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest 59(3): 138–43

    Article  PubMed  Google Scholar 

  18. Castelbaum AJ, Bigdeli H, Post KD et al. (2002) Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril 78(6): 1311–3

    Article  PubMed  Google Scholar 

  19. Robert M, Leriche-Polverelli A, Hamon P et al. (1991) Grossesse chez une femme traitée pour adénome gonadotrope. Intérêt de la bromocriptine. Presse Médicale 20: 503–5

    CAS  Google Scholar 

  20. Arita K, Uozumi T, Yano T et al. (1996) Effect of surgery on gonadal function of premenopausal women with pituitary adenomas other than prolactinomas. Endocr J 43(2): 131–8

    PubMed  CAS  Google Scholar 

  21. Scheithauer BW, Sano T, Kovacs KT et al. (1990) The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65(4): 461–74

    PubMed  CAS  Google Scholar 

  22. Gonzalez JG, Elizondo G, Saldivar D et al. (1988) Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85(2): 217–20

    Article  PubMed  CAS  Google Scholar 

  23. Elser AD, Sanders TG, Vines FS, Chen MYM (1991) Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 181: 531–5

    Google Scholar 

  24. Yap AS, Clouston WM, Mortimer RH, Drake RF (1990) Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy. Am J Obstet Gynecol 163(2): 477–8

    PubMed  CAS  Google Scholar 

  25. Bevan JS, Burke CW (1986) Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine. Clin Endocrinol 25: 561–72

    CAS  Google Scholar 

  26. Nobels FR, de Herder WW, van den Brink WM et al. (2000) Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma. Eur J Endocrinol 143: 615–21

    Article  PubMed  CAS  Google Scholar 

  27. Renner U, Mojto J, Lange M et al. (1994) Effect of bromocriptine and SMS 201–995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro. Eur J Endocrinol 130: 89–91

    Google Scholar 

  28. Molitch ME (2003) Pituitary tumors and pregnancy. Growth Horm IGF Res 13 Suppl A: 38–44

    Article  CAS  Google Scholar 

  29. Sadoul JL (2004) Adénomes à prolactine et grossesse. Médecine thérapeutique Endocrinologie et Reproduction 6(5): 300–8

    Google Scholar 

  30. Rossi AM, Vilska S, Heinonen PK (1995) Outcome of pregnancies in women with treated or untreated hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol 63(2): 143–6

    Article  PubMed  CAS  Google Scholar 

  31. Caron P, Gerbeau C, Pradayrol L (1995) Maternal-fetal transfer of octreotide. N Engl J Med 333(9): 601–2

    Article  PubMed  CAS  Google Scholar 

  32. de Menis E, Billeci D, Marton E, Gussoni G (1999) Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. J Clin Endocrinol Metab 84(4): 1489

    Article  PubMed  Google Scholar 

  33. Donadille F (2003) Gonadotroph adenoma and pregnancy: two case reports. Endocrine society, Philadelphia, P2–628

    Google Scholar 

  34. Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83(3): 727–31

    Article  PubMed  CAS  Google Scholar 

  35. Casson IF, Davis JC, Jeffreys RV et al. (1987) Successful management of Cushing’s disease during pregnancy by transsphenoidal adenectomy. Clin Endocrinol (Oxf) 27(4): 423–8

    CAS  Google Scholar 

  36. Mellor A, Harvey RD, Pobereskin LH, Sneyd JR (1998) Cushing’s disease treated by transsphenoidal selective adenomectomy in mid-pregnancy. Br J Anaesth 80(6): 850–2

    PubMed  CAS  Google Scholar 

  37. Ross RJ, Chew SL, Perry L et al. (1995) Diagnosis and selective cure of Cushing’s disease during pregnancy by transsphenoidal surgery. Eur J Endocrinol 132(6): 722–6

    Article  PubMed  CAS  Google Scholar 

  38. Chaiamnuay S, Moster M, Katz MR, Kim YN (2003) Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 6(2): 109–13

    Article  PubMed  Google Scholar 

  39. Visot A (2001) Neurochirurgie et tumeurs hypophysaires: indications chirurgicales et résultats. Presse médicale 30: 401–4

    CAS  Google Scholar 

  40. Beck-Peccoz P, Brucker-Davis F, Persani L et al. (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17(6): 610–38

    Article  PubMed  CAS  Google Scholar 

  41. Skarulis MC (2003) The clinical features of thyrotropin-secreting pituitary adenomas. Endocrine society, Philadelphia, S21–1

    Google Scholar 

  42. Brucker-Davis F, Oldfield EH, Skarulis MC et al. (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocr Metab 84: 476–86

    Article  PubMed  CAS  Google Scholar 

  43. Socin HV, Chanson P, Delemer B et al. (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148: 433–42

    Article  PubMed  CAS  Google Scholar 

  44. Chanson P, Weintraub BD, Harris AG (1993) Treatment of TSH-secreting pituitary adenomas with octreotide: a follow-up of 52 patients. Ann Intern Med 119: 236–40

    PubMed  CAS  Google Scholar 

  45. Kuhn JM, Arlot S, Lefebvre H et al. (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J. Clin Endocr Metab 85: 1487–1491

    Article  PubMed  CAS  Google Scholar 

  46. Caron P, Arlot S, Bauters C et al. (2001) Efficacy of the long-acting octreotide formulation (Octreotide-Lar) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocr Metab 86: 2849–53

    Article  PubMed  CAS  Google Scholar 

  47. Del Monte P, Bernasconi D, Ruelle A et al. (2003) Three-year treatment with Octreotide-Lar in secondary hyperthyroidism due to a TSH-secreting pituitary macroadenoma. Endocrine society, Philadelphia, P2–626

    Google Scholar 

  48. Glinoer D, de Nayer P, Bourdoux P et al. (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocr Metab 71(2): 276–87

    PubMed  CAS  Google Scholar 

  49. Caron P, Glinoer D. La fonction thyroïdienne au cours de la grossesse. Paramètres hormonaux et auto-immunité. La thyroïde, 2c éd. Elsevier p. 495–500

    Google Scholar 

  50. Brabant G, Corette L, Houze de ľAulnoit D, Ellart D (1989) Dysthyroïdie et fertilité Rev Fr Gynecol Obstet 84(12): 898–900

    CAS  Google Scholar 

  51. Joshi JV, Bhandarkar SD, Chadha M et al. (1993) Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med 39(3): 137–41

    PubMed  CAS  Google Scholar 

  52. Caron P, Gerbeau C, Pradayrol L et al. (1996) Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocr Metab 81(3): 1164–8

    Article  PubMed  CAS  Google Scholar 

  53. Blackhurst G, Strachan MW, Collie D et al. (2002) The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 57(3): 401–4

    Article  CAS  Google Scholar 

  54. Smallridge RC (1993) Thyrotropin-secreting tumours. Mazzaferri EL, Samaan NA, eds. Endocrine Tumours. Blackwell Scientific, Boston, MA, p. 136–51

    Google Scholar 

  55. Fisher DA, Dussault JH, Sack J, Chopra IJ (1976) Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 33: 59–116

    PubMed  CAS  Google Scholar 

  56. Enjalbert A, Tapia-Arancibia L, Rieutort M et al. (1982) Somatostatin receptors on rat anterior pituitary membranes. Endocrinology 110(5): 1634–40

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. F. Donadille
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Donadille, F. (2007). Adénomes non fonctionnels et thyréotropes au cours de la grossesse. In: Pathologie hypophysaire et grossesse. Springer, Paris. https://doi.org/10.1007/978-2-287-35572-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-35572-1_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-35571-4

  • Online ISBN: 978-2-287-35572-1

Publish with us

Policies and ethics

Search

Navigation